
A study has unveiled the mechanism behind the rapid waning of vaccine protection in individuals treated with TNF-α inhibitors for autoimmune diseases like Crohn's and rheumatoid arthritis. The study found that TNF-α blocker therapy hampers the production of memory B cells, essential for long-term vaccine protection. This study highlights the need for regular boosters in this patient group. The findings apply to all vaccines, emphasizing the importance of assessing vaccination status before commencing TNF-α blocker therapy to ensure lasting protection.
Like
Save
Share